A Phase 1B, Open-Label, Dose Escalation Study Evaluating the Safety of BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Iniparib (Primary) ; Carboplatin; Gemcitabine; Paclitaxel; Temozolomide; Topotecan
- Indications Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Sarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors BiPar Sciences
- 23 May 2012 Actual patient number changed from 150 to 136 as reported by ClinicalTrials.gov.
- 23 May 2012 Actual end date Sep 2011 added as reported by ClinicalTrials.gov.
- 06 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.